Catalyst Wire Dossier Catalyst Wire Dossier

Nebulised 3% Hypertonic Saline

3% hypertonic saline for nebulization · Can Tho University of Medicine and Pharmacy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nebulised 3% Hypertonic Saline, covering 2024-08-16 to 2024-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis [Phase 2, Phase 3]

See pricing